Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 2/2015

01-02-2015 | Original Paper

“Was it a Mistake to Tell Others That You are Infected with HIV?”: Factors Associated with Regret Following HIV Disclosure Among People Living with HIV in Five Countries (Mali, Morocco, Democratic Republic of the Congo, Ecuador and Romania). Results from a Community-Based Research

Authors: Emilie Henry, Adeline Bernier, Florin Lazar, Gaspard Matamba, Mohamed Loukid, Cesar Bonifaz, Samba Diop, Joanne Otis, Marie Préau, The Partages study group

Published in: AIDS and Behavior | Issue 2/2015

Login to get access

Abstract

This study examined regret following HIV serostatus disclosure and associated factors in under-investigated contexts (Mali, Morocco, Democratic Republic of the Congo, Ecuador and Romania). A community-based cross-sectional study was implemented by a mixed consortium [researchers/community-based organizations (CBO)]. Trained CBO members interviewed 1,500 PLHIV in contact with CBOs using a 125-item questionnaire. A weighted multivariate logistic regression was performed. Among the 1,212 participants included in the analysis, 290 (23.9 %) declared that disclosure was a mistake. Female gender, percentage of PLHIV’s network knowing about one’s seropositivity from a third party, having suffered rejection after disclosure, having suffered HIV-based discrimination at work, perceived seriousness of infection score, daily loneliness, property index and self-esteem score were independently associated with regret. Discrimination, as well as individual characteristics and skills may affect the disclosure experience. Interventions aiming at improving PLHIV skills and reducing their social isolation may facilitate the disclosure process and avoid negative consequences.
Literature
1.
Deribe K, Woldemichael K, Wondafrash M, Haile A, Amberbir A. Disclosure experience and associated factors among HIV positive men and women clinical service users in southwest Ethiopia. BMC Public Health. 2008;8:81.CrossRefPubMedCentralPubMed
2.
Elford J, Ibrahim F, Bukutu C, Anderson J. Disclosure of HIV status: the role of ethnicity among people living with HIV in London. J Acquir Immune Defic Syndr. 2008;47(4):514–21.CrossRefPubMed
3.
Babcock JH. Involving family and significant others in acute care. In: Aronstein DM, Thompson BJ, editors. HIV and social work. Binghamton: Harrington; 1998. p. 101–8.
4.
Hays RB, McKusick L, Pollack L, Hilliard R, Hoff C, Coates TJ. Disclosing HIV seropositivity to significant others. AIDS. 1993;7(3):425–31.CrossRefPubMed
5.
Kalichman SC. Understanding AIDS: a guide for mental health professionals. Washington, DC: Am Psychol Assoc; 1995.CrossRef
6.
Black BP, Miles MS. Calculating the risks and benefits of disclosure in African American women who have HIV. J Obstet Gynecol Neonatal Nurs. 2002;31(6):688–97.CrossRefPubMed
7.
8.
9.
Valle M, Levy J. Weighing the consequences: self-disclosure of HIV-positive status among African American injection drug users. Health Educ Behav. 2009;36(1):155–66.CrossRefPubMed
10.
Hutton VE, Misajon R, Collins FE. Subjective wellbeing and “felt” stigma when living with HIV. Qual Life Res. 2013;22(1):65–73.CrossRefPubMed
11.
Medley A, Garcia-Moreno C, McGill S, Maman S. Rates, barriers and outcomes of HIV serostatus disclosure among women in developing countries: implications for prevention of mother-to-child transmission programmes. Bull World Health Organ. 2004;82(4):299–307.PubMedCentralPubMed
12.
Spire B, Carrieri P, Sopha P, et al. Adherence to antiretroviral therapy in patients enrolled in a comprehensive care program in Cambodia: a 24-month follow-up assessment. Antivir Ther. 2008;13(5):697–703.PubMed
13.
Waddell EN, Messeri PA. Social support, disclosure, and use of antiretroviral therapy. AIDS Behav. 2006;10(3):263–72.CrossRefPubMed
14.
Holt R, Court P, Vedhara K, Nott KH, Holmes J, Snow MH. The role of disclosure in coping with HIV infection. AIDS Care. 1998;10(1):49–60.CrossRefPubMed
15.
Kalichman SC, DiMarco M, Austin J, Luke W, DiFonzo K. Stress, social support, and HIV-status disclosure to family and friends among HIV-positive men and women. J Behav Med. 2003;26(4):315–32.CrossRefPubMed
16.
Bogart LM, Landrine H, Galvan FH, Wagner GJ, Klein DJ. Perceived discrimination and physical health among HIV-positive Black and Latino men who have sex with men. AIDS Behav. 2013;17(4):1431–41.CrossRefPubMedCentralPubMed
17.
Marks G, Burris S, Peterman TA. Reducing sexual transmission of HIV from those who know they are infected: the need for personal and collective responsibility. AIDS. 1999;13(3):297–306.CrossRefPubMed
18.
Olley BO, Seedat S, Stein DJ. Self-disclosure of HIV serostatus in recently diagnosed patients with HIV in South Africa. Afr J Reprod Health. 2004;8(2):71–6.CrossRefPubMed
19.
Loubiere S, Peretti-Watel P, Boyer S, Blanche J, Abega SC, Spire B. HIV disclosure and unsafe sex among HIV-infected women in Cameroon: Results from the ANRS-EVAL study. Soc Sci Med. 2009;69(6):885–91.CrossRefPubMed
20.
Marks G, Crepaz N. HIV-positive men’s sexual practices in the context of self-disclosure of HIV status. J Acquir Immune Defic Syndr. 2001;27(1):79–85.CrossRefPubMed
21.
Sullivan KM. Male self-disclosure of HIV-positive serostatus to sex partners: a review of the literature. J Assoc Nurses AIDS Care. 2005;16(6):33–47.CrossRefPubMed
22.
Chaudoir SR, Fisher JD, Simoni JM. Understanding HIV disclosure: a review and application of the disclosure processes model. Soc Sci Med. 2011;72(10):1618–29.CrossRefPubMedCentralPubMed
23.
Serovich JM, McDowell TL, Grafsky EL. Women’s report of regret of hiv disclosure to family, friends and sex partners. AIDS Behav. 2008;12(2):227–31.CrossRefPubMedCentralPubMed
24.
Serovich JM, Mason TL, Bautista D, Toviessi P. Gay men’s report of regret of HIV disclosure to family, friends, and sex partners. AIDS Educ Prev. 2006;18(2):132–8.CrossRefPubMedCentralPubMed
25.
26.
Murphy DA, Roberts KJ, Hoffman D. Regrets and advice from mothers who have disclosed their HIV+ serostatus to their young children. J Child Fam Stud. 2003;12(3):307–18.CrossRef
27.
Henry E., Verde L., Cissé M et al: Linking research and intervention: a community research program on serostatus disclosure in five countries: Mali, Morocco, DRC, Ecuador and Romania. XIX International AIDS Conference, Washington, 2012 [abstract MOPE398].
28.
Lazăr F, Verde L, Henry E, et al. Satisfaction with sexual life in people living with HIV in Romania, together with associated individual and social factors. AIDS Care. 2014;26(Suppl 1):S65–9.CrossRefPubMed
29.
Mosavel M, Simon C, van Stade D, Buchbinder M. Community-based participatory research (CBPR) in South Africa: engaging multiple constituents to shape the research question. Soc Sci Med. 2005;61(12):2577–87.CrossRefPubMedCentralPubMed
30.
Israel BA, Schulz AJ, Parker EA, Becker AB. Review of community-based research: assessing partnership approaches to improve public health. Annu Rev Public Health. 1998;19:173–202.CrossRefPubMed
31.
Loukid M, Abadie A, Henry E, et al. Factors associated with HIV status disclosure to one’s steady sexual partner in PLHIV in Morocco. J Community Health. 2014;39(1):50–9.CrossRefPubMed
32.
Gadermann AM, Guhn M, Zumbo BD. Estimating ordinal reliability for Likert-type and ordinal item response data: a conceptual, empirical, and practical guide. Pract Assess Res Eval. 2012;17(3). http://​pareonline.​net/​pdf/​v17n3.​pdf. Accessed 5 April 2014.
33.
Moss-Morris R, Weinman J, Petrie KJ, Horne R, Cameron LD, Buick D. The revised illness perception questionnaire (IPQ-R). Psychol Health. 2002;17:1–16.CrossRef
34.
Rosenberg M. Society and the adolescent self-image. Princeton: Princeton University Press; 1965.
35.
Martinot D. Connaissance de soi et estime de soi : ingrédients pour la réussite scolaire. Rev Sci Educ. 2001;27(3):483–502.
36.
Schwarzer R, Jerusalem M. Generalized self-efficacy scale. In: Weinman J, Wright S, Johnston M, editors. Measures in health psychology: a user’s portfolio. Causal and control beliefs. Windsor: NFER-NELSON; 1995. p. 35–7.
37.
38.
Dima AL, Stutterheim SE, Lyimo R, de Bruin M. Advancing methodology in the study of HIV status disclosure: the importance of considering disclosure target and intent. Soc Sci Med. 2014;108:166–74.CrossRefPubMed
39.
Connell RW. Gender and power: society, the person and sexual politics. Palo Alto: Stanford University Press; 1987.
40.
41.
Weiss E, Whelan D, Gupta GR. Gender, sexuality and HIV: making a difference in the lives of young women in developing countries. Sex Relatsh Ther. 2000;15(3):233–45.CrossRef
42.
43.
Blanc AK. The effect of power in sexual relationships on sexual and reproductive health: an examination of the evidence. Stud Fam Plann. 2001;32(3):189–213.CrossRefPubMed
44.
45.
Grodensky CA, Golin CE, Jones C, et al. “I Should Know Better”: the roles of relationships, spirituality, disclosure, stigma, and shame for older women living with HIV seeking support in the South. J Assoc Nurses AIDS Care. 2014;. doi:10.​1016/​j.​jana.​2014.​01.​005.PubMed
46.
Lowther K, Selman L, Harding R, Higginson IJ. Experience of persistent psychological symptoms and perceived stigma among people with HIV on antiretroviral therapy (ART): a systematic review. Int J Nurs Stud. 2014;51(8):1171–89.CrossRefPubMed
47.
48.
Colbert AM, Kim KH, Sereika SM, Erlen JA. An examination of the relationships among gender, health status, social support, and HIV-related stigma. J Assoc Nurses AIDS Care. 2010;21(4):302–13.CrossRefPubMedCentralPubMed
49.
Asiedu GB, Myers-Bowman KS. Gender differences in the experiences of HIV/AIDS-related stigma: a qualitative study in Ghana. Health Care Women Int. 2014;35(7–9):703–27.CrossRefPubMed
50.
Beaulieu M, Otis J, Blais M, et al. A model of quality of life of women living with HIV. J HIV AIDS Soc Serv. 2012;11(3):210–32.CrossRef
51.
Zamudio-Haas S, Mudekunye-Mahaka I, Lambdin BH, Dunbar MS. If, when and how to tell: a qualitative study of HIV disclosure among young women in Zimbabwe. Reprod Health Matters. 2012;20(39 Suppl):18–26.CrossRefPubMed
52.
King EB, Botsford WE. Managing pregnancy disclosures: understanding and overcoming the challenges of expectant motherhood at work. Hum Resour Manag Rev. 2009;19(4):314–23.CrossRef
53.
Ezegwui HU, Nwogu-Ikojo EE, Enwereji JO, Dim CC. HIV serostatus disclosure pattern among pregnant women in Enugu, Nigeria. J Biosoc Sci. 2009;41(6):789–98.CrossRefPubMed
54.
Orne-Gliemann J, Tchendjou P, Miric M et al. Conseil prénatal pour le VIH orienté vers le couple dans quatre pays à faible et moyenne prévalences: acceptabilité et faisabilité. In: Desclaux A, Msellati P, Sow K. Les femmes à l’épreuve du VIH dans les pays du Sud, Genre et accès universel à la prise en charge. Paris: ANRS, Collection Sciences Sociales et Sida; 2011.
55.
56.
Gaskins SW, Payne Foster P, Sowell RL, Lewis TL, Gardner A, Parton JM. Making decisions: the process of HIV disclosure for rural African American men. Am J Mens Health. 2012;6(6):442–52.CrossRefPubMed
57.
Liu Y, Canada K, Shi K, Corrigan P. HIV-related stigma acting as predictors of unemployment of people living with HIV/AIDS. AIDS Care. 2012;24(1):129–35.CrossRefPubMed
58.
Bashir S. HIV/AIDS stigma at the workplace: exploratory findings from Pakistan. SAHARA J. 2011;8(3):156–61.CrossRefPubMed
59.
Dray-Spira R, Lert F. VESPA Study Group. Living and working with HIV in France in 2003: results from the ANRS-EN12-VESPA Study. AIDS. 2007;21(Suppl 1):S29–36.CrossRefPubMed
60.
Rodkjaer L, Sodemann M, Ostergaard L, Lomborg K. Disclosure decisions: HIV-positive persons coping with disease-related stressors. Qual Health Res. 2011;21(9):1249–59.CrossRefPubMed
61.
62.
Bury M. The sociology of chronic illness: a review of research and prospects. Sociol Health Illn. 1991;13(4):451–68.CrossRef
63.
Charmaz K. Struggling for a self: identity levels of the chronically ill. In: Roth JA, Conrad P, editors. Research in the sociology of health care: Vol. 6. The experience and management of chronic illness. Greenwich, CT: JAI Press; 1987. pp. 283–321.
64.
Galletly CL, Pinkerton SD, DiFranceisco W. A quantitative study of Michigan’s criminal HIV exposure law. AIDS Care. 2012;24(2):174–9.PubMedCentralPubMed
65.
Fuhrer R, Rouillon F. La version française de l’échelle CES-D (Center for Epidemiologic Studies-Depression Scale) Description et traduction de l’échelle d’auto-évaluation. Psychiatr Psychobiol. 1989;4:163–6.
66.
Bates I, Fenton C, Gruber J, et al. Vulnerability to malaria, tuberculosis, and HIV/AIDS infection and disease. Part 1: determinants operating at individual and household level. Lancet Infect Dis. 2004;4(5):267–77.CrossRefPubMed
67.
Booysen Fle R, Summerton J. Poverty, risky sexual behaviour, and vulnerability to HIV infection: evidence from South Africa. J Health Popul Nutr. 2002;20(4):285–8.PubMed
68.
Ncama BP. Acceptance and disclosure of HIV status through an integrated community/home-based care program in South Africa. Int Nurs Rev. 2007;54(4):391–7.CrossRefPubMed
69.
Otis J, Yattassaye A, Henry E, et al. Effects of an empowerment program on the ability of women living with HIV in Mali to manage decisions regarding whether or not to disclose HIV status. XIX International AIDS Conference. Washington, 2012 [abstract MOPE502].
70.
Metadata
Title
“Was it a Mistake to Tell Others That You are Infected with HIV?”: Factors Associated with Regret Following HIV Disclosure Among People Living with HIV in Five Countries (Mali, Morocco, Democratic Republic of the Congo, Ecuador and Romania). Results from a Community-Based Research
Authors
Emilie Henry
Adeline Bernier
Florin Lazar
Gaspard Matamba
Mohamed Loukid
Cesar Bonifaz
Samba Diop
Joanne Otis
Marie Préau
The Partages study group
Publication date
01-02-2015
Publisher
Springer US
Published in
AIDS and Behavior / Issue 2/2015
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-014-0976-8

Other articles of this Issue 2/2015

AIDS and Behavior 2/2015 Go to the issue

Original Paper

Improving Hospital-Based Quality of Care by Reducing HIV-Related Stigma: Evaluation Results from Vietnam

Original Paper

Socioeconomic Gradients in Internalized Stigma Among 4,314 Persons with HIV in Sub-Saharan Africa

Original Paper

Sexual Orientation- and Race-Based Discrimination and Sexual HIV Risk Behavior Among Urban MSM

Original Paper

The Efficacy of Serostatus Disclosure for HIV Transmission Risk Reduction

Original Paper

Development of a Brief Substance Use Sensation Seeking Scale: Validation and Prediction of Injection-Related Behaviors

Original Paper

HIV-Positive Status Disclosure in Patients in Care in Rural South Africa: Implications for Scaling Up Treatment and Prevention Interventions
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits